Continuous Intravenous Drug Infusion (Biomedical Engineering) Solution

Problem Overview

We evaluate the continuous limit ($n \to \infty$) of a discrete drug clearance concentration profile:

Step-by-Step Mathematical Solution

Step 1: Logarithmic Transformation & Convergence Proof

The governing methodology is the Logarithmic Transformation Algorithm for Indeterminate Powers:

1. Classify the Indeterminate Form: As $n \to \infty$, the base is $1 + \frac{kt}{n} \to 1$, while the exponent is $-n \to -\infty$. This constitutes the indeterminate power form $1^{-\infty} = \frac{1}{1^\infty}$, which is fundamentally of type $1^\infty$.

2. Execute the Logarithmic Transformation: Let $y = \left(1 + \frac{kt}{n}\right)^{-n}$. Taking the natural logarithm of both sides:

   $$\ln y = \ln\left[\left(1 + \frac{kt}{n}\right)^{-n}\right] = -n \ln\left(1 + \frac{kt}{n}\right)$$
   As $n \to \infty$, this takes the indeterminate product form $-\infty \cdot \ln(1) = -\infty \cdot 0$.

3. Convert to a Quotient for L'Hôpital's Rule: Push $n$ into the denominator as $n^{-1} = \frac{1}{n}$:

   $$\lim_{n \to \infty} \ln y = \lim_{n \to \infty} \frac{-\ln\left(1 + kt n^{-1}\right)}{n^{-1}}$$
   Direct substitution gives $\frac{-\ln(1)}{0} = \frac{0}{0}$. The conditions for L'Hôpital's Rule are satisfied.

4. Differentiate Numerator and Denominator with Respect to $n$: Numerator derivative using the Chain Rule:

   $$\frac{d}{dn}\left[-\ln\left(1 + kt n^{-1}\right)\right] = -\frac{1}{1 + kt n^{-1}} \cdot \left(-kt n^{-2}\right) = \frac{kt n^{-2}}{1 + \frac{kt}{n}}$$
   Denominator derivative using the Power Rule:
   $$\frac{d}{dn}\left[n^{-1}\right] = -n^{-2}$$

5. Evaluate the Limit of $\ln y$:

   $$\lim_{n \to \infty} \ln y \overset{\text{L'H}}{=} \lim_{n \to \infty} \frac{\frac{kt n^{-2}}{1 + \frac{kt}{n}}}{-n^{-2}} = \lim_{n \to \infty} \left[-\frac{kt}{1 + \frac{kt}{n}}\right]$$
   As $n \to \infty$, the term $\frac{kt}{n} \to 0$:
   $$L = \lim_{n \to \infty} \ln y = -\frac{kt}{1 + 0} = -kt$$

6. Exponentiate to Recover the Original Limit:

   $$\lim_{n \to \infty} y = e^L = e^{-kt}$$
   Multiplying by the initial concentration constant $C_0$:
   $$C(t) = \lim_{n \to \infty} C_n(t) = C_0 e^{-kt}$$
   (Q.E.D. The discrete infusion model rigorously converges to continuous exponential clearance.)

Step 2: Numerical Concentration Comparison at $t = 8.0\text{ hours}$

Given parameters: $C_0 = 50.0\text{ mg/L}$, $k = 0.150\text{ hr}^{-1}$, and $t = 8.0\text{ hr}$. The exponential factor is:

1. Continuous Infusion Limit ($n \to \infty$):

   $$C(8.0) = 50.0 \cdot e^{-1.20} = 50.0 \cdot (0.301194) \approx 15.06\text{ mg/L}$$

2. Low-Frequency Discrete Dosing ($n = 2\text{ boluses/hr}$):

   $$C_2(8.0) = 50.0 \left(1 + \frac{1.20}{2}\right)^{-2} = 50.0 (1 + 0.60)^{-2} = 50.0 (1.60)^{-2} = \frac{50.0}{2.56} \approx 19.53\text{ mg/L}$$
   • Notice that the discrete delivery model over-predicts remaining circulating drug concentration by $(19.53 - 15.06) / 15.06 \approx 29.7\%$, illustrating that coarse discrete dosing models introduce severe kinetic error compared to continuous physiological clearance.

Step 3: Clinical Implications & Closed-Loop Control

1. Saw-Tooth Spikes vs. Smooth Perfusion: In discrete bolus injections, drug concentration rises sharply to a toxic peak immediately after injection, then drops below the minimum effective concentration (MEC) before the next dose. This "saw-tooth" fluctuation risks toxic organ damage at the peak and therapeutic failure in the valley.
2. Firmware Validation in Smart Pumps: Automated insulin pumps and anesthesia delivery controllers adjust stepper motors to administer hundreds of micro-units per minute, operating near the mathematical continuum $n \to \infty$. By proving that $\lim_{n \to \infty} C_n(t) = C_0 e^{-kt}$, biomedical software engineers can safely program PID (proportional-integral-derivative) feedback loops based on clean exponential differential equations ($C'(t) = -k C(t)$) rather than complex, computationally intensive discrete recurrence relations.

Engineering Conclusion

In pharmacokinetic modeling, discrete dosing intervals create indeterminate forms of the type $1^\infty$ as delivery frequency approaches continuous infusion. Direct intuition might erroneously suggest that $1^\infty = 1$, which would imply the drug never clears from the patient's body!

Applying the 4-step Logarithmic Transformation Algorithm and L'Hôpital's Rule proves that the base-exponent interaction yields an exact exponential decay factor $e^{-kt}$. This derivation provides the foundational mathematical bridge connecting discrete medical device hardware (stepper motor pump pulses) to continuous physiological pharmacology, ensuring patients receive stable, life-saving therapeutic dosing within tight safety margins.